Answer
Hair loss (alopecia) is very common during gemcitabine hydrochloride treatment, affecting at least 1 in 10 patients in clinical trial data; adverse-reaction frequency and severity are affected by dose, infusion rate and intervals between doses.
Sources for this answer
- Gemcitabine 38 mg/ml Concentrate for Solution for InfusionHospira UK Ltd · emc · SmPC §4.8 Undesirable effects · Version 15Document updated
Sources checked